MCL1/BCL2L1 showed a similar distribution to ATP1A1/BCL2L1 among FAB subtypes in AML patient (p-value < 0.001) and cell line cohorts (p-value = 0.0018); Supplementary Fig. S13A–C). This evidence concerns the gene BCL2L1 and acute myeloid leukemia.